Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering ...

Failure to make findings of fact adds twist to battle over Eliquis in Ireland ...

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

AstraZeneca fends off diabetes generic, for now ...

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...